Business
Avivagen Secures First Sale of OxC-beta™ Livestock in Brazil
Avivagen Secures First Sale of OxC-beta™ Livestock in Brazil.
About this update from Avivagen, Inc.
[{"type":"text","content":"\nAvivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and performance, is pleased to announce that it has recorded its first sale of OxC-beta™ Livestock in Brazil. The 125 kg purchase was made by Look Chemicals, Avivagen’s distribution partner in Brazil, and represents an introductory order as the company begins to roll out the use of the product in the market.\n\n\n“We are very excited to announce our first order of OxC-beta™ Livestock in Brazil, one of the largest and most important livestock feed markets in the world,” said Kym Anthony, Chief Executive Officer of Avivagen. “Similar to our experience with our initial orders with UNAHCO in the Philippines and Industrias Melder in Mexico, we are confident that demand for OxC-beta™ Livestock will grow once this initial order is fully utilized.”\n\n\nBrazil is the world’s third largest livestock feed market, consuming 69 million tonnes of livestock feed each year, and key exporter of livestock to regions that have previously implemented bans against the use of antibiotics in livestock feedi, including Europe.\n\n\n____________________________________\n\n\ni https://www.alltech.com/press-release/2019-alltech-global-feed-survey-estimates-world-feed-production-increased-3-percent\n\n\nAbout Avivagen\n\n\nAvivagen is a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications. By unlocking an overlooked facet of β-carotene activity, a path has been opened to safely and economically support immune function, thereby promoting general health and performance in animals. Avivagen is a public corporation traded on the TSX Venture Exchange under the symbol VIV and is headquartered in Ottawa, Canada, based in partnership facilities of the National Research Council of Canada and Charlottetown, Prince Edward Island. For more information, visit www.avivagen.com. The contents of the website are expressly not incorporated by reference in this press release.\n\n\nAbout OxC-beta™ Technology and OxC-beta™ Livestock\n\n\nAvivagen̵...